| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Lupus Erythematosus, Systemic | 106 | 2022 | 991 | 7.950 |
Why?
|
| Genetic Predisposition to Disease | 90 | 2022 | 666 | 5.860 |
Why?
|
| Polymorphism, Single Nucleotide | 80 | 2022 | 547 | 4.080 |
Why?
|
| Haplotypes | 48 | 2021 | 283 | 3.520 |
Why?
|
| Genome-Wide Association Study | 27 | 2022 | 234 | 2.040 |
Why?
|
| DNA-Binding Proteins | 15 | 2021 | 490 | 1.890 |
Why?
|
| Chromatin | 6 | 2021 | 76 | 1.810 |
Why?
|
| Autoimmune Diseases | 12 | 2021 | 164 | 1.710 |
Why?
|
| Genetic Variation | 15 | 2021 | 242 | 1.580 |
Why?
|
| Nuclear Proteins | 7 | 2018 | 247 | 1.450 |
Why?
|
| Alleles | 36 | 2020 | 350 | 1.360 |
Why?
|
| Intracellular Signaling Peptides and Proteins | 7 | 2017 | 281 | 1.330 |
Why?
|
| Linkage Disequilibrium | 18 | 2021 | 108 | 1.210 |
Why?
|
| Humans | 148 | 2022 | 28094 | 1.200 |
Why?
|
| Ubiquitin-Conjugating Enzymes | 2 | 2021 | 15 | 1.140 |
Why?
|
| Quantitative Trait Loci | 6 | 2021 | 55 | 1.100 |
Why?
|
| Genome, Human | 6 | 2018 | 69 | 1.020 |
Why?
|
| Promoter Regions, Genetic | 10 | 2021 | 343 | 0.990 |
Why?
|
| Enhancer Elements, Genetic | 3 | 2021 | 24 | 0.970 |
Why?
|
| Genetic Loci | 12 | 2018 | 76 | 0.950 |
Why?
|
| Genotype | 35 | 2020 | 456 | 0.920 |
Why?
|
| Tumor Necrosis Factor alpha-Induced Protein 3 | 6 | 2016 | 24 | 0.890 |
Why?
|
| Interferon Regulatory Factors | 9 | 2016 | 57 | 0.870 |
Why?
|
| src-Family Kinases | 6 | 2016 | 71 | 0.840 |
Why?
|
| Autoimmunity | 8 | 2020 | 157 | 0.840 |
Why?
|
| Case-Control Studies | 37 | 2021 | 722 | 0.830 |
Why?
|
| Male | 66 | 2022 | 13489 | 0.790 |
Why?
|
| Mutation | 8 | 2020 | 845 | 0.790 |
Why?
|
| Female | 71 | 2021 | 15153 | 0.780 |
Why?
|
| YY1 Transcription Factor | 1 | 2021 | 1 | 0.770 |
Why?
|
| CCCTC-Binding Factor | 1 | 2021 | 2 | 0.760 |
Why?
|
| Gene Expression Regulation | 10 | 2021 | 632 | 0.750 |
Why?
|
| African Americans | 19 | 2018 | 352 | 0.720 |
Why?
|
| Polymorphism, Genetic | 9 | 2018 | 165 | 0.720 |
Why?
|
| NF-kappa B | 5 | 2016 | 191 | 0.680 |
Why?
|
| Genetic Linkage | 8 | 2011 | 95 | 0.670 |
Why?
|
| DNA | 6 | 2020 | 374 | 0.660 |
Why?
|
| Phenotype | 13 | 2016 | 680 | 0.650 |
Why?
|
| Lupus Nephritis | 6 | 2014 | 102 | 0.640 |
Why?
|
| Molecular Conformation | 1 | 2018 | 67 | 0.600 |
Why?
|
| B-Lymphocytes | 8 | 2020 | 283 | 0.600 |
Why?
|
| Gene Expression | 6 | 2021 | 417 | 0.580 |
Why?
|
| Arthritis, Rheumatoid | 6 | 2022 | 134 | 0.570 |
Why?
|
| Risk Factors | 19 | 2022 | 2081 | 0.550 |
Why?
|
| Sjogren's Syndrome | 6 | 2022 | 263 | 0.540 |
Why?
|
| Sequence Analysis, DNA | 6 | 2014 | 369 | 0.530 |
Why?
|
| Epistasis, Genetic | 5 | 2013 | 24 | 0.520 |
Why?
|
| Chromosomes, Human, Pair 16 | 5 | 2018 | 20 | 0.500 |
Why?
|
| Rheumatic Diseases | 2 | 2014 | 33 | 0.480 |
Why?
|
| Genotyping Techniques | 2 | 2016 | 21 | 0.470 |
Why?
|
| Pedigree | 12 | 2020 | 155 | 0.460 |
Why?
|
| Apoptosis | 7 | 2020 | 775 | 0.450 |
Why?
|
| Genetic Association Studies | 14 | 2018 | 112 | 0.450 |
Why?
|
| HLA Antigens | 8 | 2017 | 61 | 0.450 |
Why?
|
| HEK293 Cells | 7 | 2020 | 187 | 0.450 |
Why?
|
| Membrane Proteins | 7 | 2018 | 484 | 0.440 |
Why?
|
| Head and Neck Neoplasms | 2 | 2006 | 87 | 0.430 |
Why?
|
| Autoantibodies | 10 | 2022 | 474 | 0.410 |
Why?
|
| Limb Deformities, Congenital | 1 | 2012 | 3 | 0.400 |
Why?
|
| Scalp Dermatoses | 1 | 2012 | 4 | 0.400 |
Why?
|
| Immunoglobulin J Recombination Signal Sequence-Binding Protein | 1 | 2012 | 6 | 0.400 |
Why?
|
| Ectodermal Dysplasia | 1 | 2012 | 6 | 0.400 |
Why?
|
| NADPH Oxidases | 5 | 2017 | 69 | 0.390 |
Why?
|
| Major Histocompatibility Complex | 5 | 2018 | 28 | 0.390 |
Why?
|
| Transcription, Genetic | 1 | 2014 | 403 | 0.390 |
Why?
|
| Chromosomes, Human, Pair 6 | 4 | 2016 | 19 | 0.370 |
Why?
|
| Exons | 2 | 2010 | 42 | 0.370 |
Why?
|
| Gene Expression Profiling | 9 | 2021 | 453 | 0.350 |
Why?
|
| Base Sequence | 10 | 2018 | 584 | 0.350 |
Why?
|
| Cohort Studies | 14 | 2022 | 887 | 0.350 |
Why?
|
| STAT4 Transcription Factor | 6 | 2018 | 23 | 0.330 |
Why?
|
| Chromosome Mapping | 10 | 2020 | 130 | 0.330 |
Why?
|
| Adult | 26 | 2019 | 7739 | 0.320 |
Why?
|
| American Native Continental Ancestry Group | 4 | 2017 | 22 | 0.320 |
Why?
|
| Microcephaly | 2 | 2020 | 8 | 0.320 |
Why?
|
| Lod Score | 5 | 2006 | 36 | 0.310 |
Why?
|
| Antibodies, Antinuclear | 6 | 2017 | 183 | 0.310 |
Why?
|
| Leukocytes, Mononuclear | 5 | 2020 | 82 | 0.310 |
Why?
|
| Ostreidae | 2 | 2005 | 3 | 0.300 |
Why?
|
| Transcription Factors | 4 | 2021 | 520 | 0.300 |
Why?
|
| Gene Frequency | 12 | 2020 | 185 | 0.290 |
Why?
|
| Signal Transduction | 9 | 2016 | 1435 | 0.290 |
Why?
|
| STAT1 Transcription Factor | 3 | 2018 | 38 | 0.290 |
Why?
|
| Arthritis, Juvenile | 2 | 2021 | 9 | 0.290 |
Why?
|
| RNA, Messenger | 4 | 2018 | 659 | 0.280 |
Why?
|
| Middle Aged | 19 | 2019 | 7137 | 0.280 |
Why?
|
| Chromosomes, Human, Pair 20 | 2 | 2006 | 5 | 0.270 |
Why?
|
| HLA-DRB1 Chains | 8 | 2016 | 33 | 0.260 |
Why?
|
| Chromosomes, Human, Pair 8 | 3 | 2016 | 14 | 0.260 |
Why?
|
| Carcinoma, Adenoid Cystic | 1 | 2006 | 9 | 0.260 |
Why?
|
| Animals | 20 | 2020 | 10415 | 0.260 |
Why?
|
| Neoplasm Proteins | 3 | 2014 | 123 | 0.250 |
Why?
|
| Salivary Gland Neoplasms | 1 | 2006 | 22 | 0.250 |
Why?
|
| Carrier Proteins | 3 | 2017 | 252 | 0.250 |
Why?
|
| Gene Regulatory Networks | 2 | 2018 | 77 | 0.250 |
Why?
|
| Adaptor Proteins, Signal Transducing | 3 | 2012 | 163 | 0.250 |
Why?
|
| Molecular Sequence Data | 9 | 2014 | 1051 | 0.240 |
Why?
|
| DNA, Mitochondrial | 1 | 2005 | 82 | 0.240 |
Why?
|
| OX40 Ligand | 4 | 2016 | 16 | 0.230 |
Why?
|
| HLA-DR Antigens | 4 | 2010 | 29 | 0.230 |
Why?
|
| Mutation, Missense | 4 | 2013 | 69 | 0.230 |
Why?
|
| Protein Tyrosine Phosphatase, Non-Receptor Type 22 | 3 | 2013 | 14 | 0.230 |
Why?
|
| Nerve Tissue Proteins | 3 | 2018 | 153 | 0.220 |
Why?
|
| Multiprotein Complexes | 2 | 2017 | 54 | 0.220 |
Why?
|
| Genetic Testing | 2 | 2006 | 68 | 0.220 |
Why?
|
| Interferon-alpha | 2 | 2016 | 50 | 0.220 |
Why?
|
| Interferon Type I | 2 | 2017 | 56 | 0.220 |
Why?
|
| Gastrointestinal Microbiome | 2 | 2015 | 123 | 0.210 |
Why?
|
| Interleukin-1 Receptor-Associated Kinases | 3 | 2016 | 14 | 0.210 |
Why?
|
| Nuclear Family | 3 | 2019 | 12 | 0.210 |
Why?
|
| Electrophoretic Mobility Shift Assay | 2 | 2014 | 50 | 0.210 |
Why?
|
| Polymerase Chain Reaction | 3 | 2012 | 269 | 0.210 |
Why?
|
| Inflammation | 3 | 2017 | 636 | 0.200 |
Why?
|
| Logistic Models | 8 | 2018 | 407 | 0.200 |
Why?
|
| CD11b Antigen | 4 | 2016 | 42 | 0.200 |
Why?
|
| Receptors, Complement 3d | 2 | 2014 | 7 | 0.200 |
Why?
|
| High-Throughput Nucleotide Sequencing | 2 | 2020 | 109 | 0.200 |
Why?
|
| Oligonucleotide Array Sequence Analysis | 5 | 2006 | 194 | 0.190 |
Why?
|
| Carcinoma, Squamous Cell | 1 | 2004 | 163 | 0.190 |
Why?
|
| Erythropoiesis | 1 | 2021 | 9 | 0.190 |
Why?
|
| Young Adult | 12 | 2018 | 2732 | 0.190 |
Why?
|
| Genetic Markers | 6 | 2012 | 93 | 0.190 |
Why?
|
| Magnetic Resonance Imaging | 4 | 2008 | 819 | 0.180 |
Why?
|
| Interferons | 4 | 2012 | 69 | 0.180 |
Why?
|
| Indians, North American | 3 | 2015 | 520 | 0.180 |
Why?
|
| Cell Cycle Proteins | 2 | 2020 | 187 | 0.180 |
Why?
|
| Risk Assessment | 3 | 2020 | 612 | 0.180 |
Why?
|
| Methyl-CpG-Binding Protein 2 | 2 | 2012 | 16 | 0.180 |
Why?
|
| RNA Splicing Factors | 1 | 2020 | 1 | 0.180 |
Why?
|
| Peptidylprolyl Isomerase | 1 | 2020 | 3 | 0.180 |
Why?
|
| Models, Genetic | 4 | 2018 | 125 | 0.180 |
Why?
|
| Spliceosomes | 1 | 2020 | 11 | 0.180 |
Why?
|
| Cerebellar Diseases | 1 | 2020 | 4 | 0.180 |
Why?
|
| Immunity, Innate | 3 | 2013 | 226 | 0.180 |
Why?
|
| Skin Diseases | 1 | 2021 | 29 | 0.180 |
Why?
|
| Apoptosis Regulatory Proteins | 1 | 2020 | 33 | 0.180 |
Why?
|
| Down-Regulation | 3 | 2020 | 199 | 0.180 |
Why?
|
| Vitamin D | 2 | 2022 | 50 | 0.170 |
Why?
|
| Asian Americans | 4 | 2013 | 40 | 0.170 |
Why?
|
| Microsatellite Repeats | 4 | 2006 | 56 | 0.170 |
Why?
|
| Psoriasis | 1 | 2020 | 7 | 0.170 |
Why?
|
| Mice | 10 | 2020 | 4650 | 0.170 |
Why?
|
| HLA-C Antigens | 2 | 2017 | 13 | 0.170 |
Why?
|
| CD4-Positive T-Lymphocytes | 1 | 2021 | 106 | 0.170 |
Why?
|
| Sarcoidosis | 2 | 2017 | 38 | 0.160 |
Why?
|
| Interferon-Induced Helicase, IFIH1 | 2 | 2017 | 11 | 0.160 |
Why?
|
| United States | 6 | 2017 | 2146 | 0.160 |
Why?
|
| Genetic Pleiotropy | 2 | 2017 | 9 | 0.160 |
Why?
|
| Contrast Media | 5 | 2008 | 96 | 0.160 |
Why?
|
| Herpesviridae Infections | 1 | 2019 | 17 | 0.160 |
Why?
|
| Antigens, Viral | 1 | 2019 | 24 | 0.160 |
Why?
|
| B-Lymphocyte Subsets | 2 | 2016 | 30 | 0.160 |
Why?
|
| Herpesvirus 4, Human | 1 | 2019 | 42 | 0.150 |
Why?
|
| Child | 8 | 2021 | 2242 | 0.150 |
Why?
|
| Fibrin | 4 | 2006 | 17 | 0.150 |
Why?
|
| Chromosomes, Human, X | 3 | 2016 | 38 | 0.150 |
Why?
|
| Protein Structure, Tertiary | 3 | 2020 | 284 | 0.150 |
Why?
|
| Antibodies, Viral | 1 | 2019 | 79 | 0.150 |
Why?
|
| Chromosomes, Human, Pair 4 | 3 | 2011 | 16 | 0.150 |
Why?
|
| Bone Diseases, Developmental | 1 | 2018 | 6 | 0.150 |
Why?
|
| Serine Endopeptidases | 1 | 2018 | 18 | 0.150 |
Why?
|
| Muscle Hypotonia | 1 | 2018 | 3 | 0.150 |
Why?
|
| Motor Neuron Disease | 1 | 2018 | 3 | 0.150 |
Why?
|
| Spectrin | 1 | 2018 | 4 | 0.150 |
Why?
|
| Proprotein Convertases | 1 | 2018 | 11 | 0.150 |
Why?
|
| Eosinophilic Esophagitis | 1 | 2018 | 4 | 0.150 |
Why?
|
| beta Karyopherins | 2 | 2016 | 13 | 0.150 |
Why?
|
| Axons | 1 | 2018 | 24 | 0.150 |
Why?
|
| Intellectual Disability | 1 | 2018 | 16 | 0.150 |
Why?
|
| Protein Transport | 1 | 2018 | 158 | 0.140 |
Why?
|
| Heart Block | 1 | 2017 | 43 | 0.140 |
Why?
|
| Nephrosis | 1 | 2017 | 2 | 0.140 |
Why?
|
| Hernia, Hiatal | 1 | 2017 | 4 | 0.140 |
Why?
|
| Genetic Load | 1 | 2017 | 6 | 0.140 |
Why?
|
| Models, Molecular | 3 | 2017 | 452 | 0.140 |
Why?
|
| 2',5'-Oligoadenylate Synthetase | 1 | 2017 | 9 | 0.140 |
Why?
|
| Interleukins | 3 | 2017 | 112 | 0.140 |
Why?
|
| Interleukin-6 | 2 | 2017 | 193 | 0.140 |
Why?
|
| Chemokine CXCL10 | 1 | 2017 | 22 | 0.140 |
Why?
|
| Depressive Disorder, Major | 1 | 2018 | 127 | 0.130 |
Why?
|
| Amino Acid Sequence | 5 | 2020 | 689 | 0.130 |
Why?
|
| Vitamin D3 24-Hydroxylase | 1 | 2016 | 4 | 0.130 |
Why?
|
| Receptors, Purinergic P2Y2 | 1 | 2016 | 3 | 0.130 |
Why?
|
| Autophagy-Related Proteins | 1 | 2016 | 9 | 0.130 |
Why?
|
| Liver Cirrhosis, Biliary | 1 | 2016 | 10 | 0.130 |
Why?
|
| Sex Chromosome Disorders of Sex Development | 1 | 2016 | 11 | 0.130 |
Why?
|
| Adaptive Immunity | 2 | 2013 | 38 | 0.130 |
Why?
|
| HLA-D Antigens | 1 | 2016 | 6 | 0.130 |
Why?
|
| Cell Line, Transformed | 3 | 2012 | 42 | 0.130 |
Why?
|
| Nicotinamide-Nucleotide Adenylyltransferase | 1 | 2016 | 4 | 0.130 |
Why?
|
| Sex Chromosome Aberrations | 2 | 2016 | 16 | 0.130 |
Why?
|
| Vitamin D Deficiency | 1 | 2016 | 31 | 0.130 |
Why?
|
| Chromosomes, Human, Pair 12 | 1 | 2016 | 13 | 0.130 |
Why?
|
| Europe | 5 | 2017 | 98 | 0.120 |
Why?
|
| Trans-Activators | 2 | 2018 | 118 | 0.120 |
Why?
|
| Receptors, Interleukin | 2 | 2013 | 12 | 0.120 |
Why?
|
| Proto-Oncogene Protein c-ets-1 | 1 | 2015 | 5 | 0.120 |
Why?
|
| Protein Binding | 6 | 2015 | 658 | 0.120 |
Why?
|
| Adolescent | 7 | 2021 | 3121 | 0.120 |
Why?
|
| Diet, Paleolithic | 1 | 2015 | 6 | 0.120 |
Why?
|
| Phosphoproteins | 2 | 2011 | 120 | 0.120 |
Why?
|
| Leptin | 1 | 2015 | 67 | 0.120 |
Why?
|
| Sequence Inversion | 1 | 2014 | 1 | 0.120 |
Why?
|
| CD3 Complex | 1 | 2015 | 23 | 0.120 |
Why?
|
| Odds Ratio | 5 | 2017 | 236 | 0.120 |
Why?
|
| Agriculture | 1 | 2015 | 44 | 0.120 |
Why?
|
| Interleukin-2 | 2 | 2011 | 35 | 0.110 |
Why?
|
| Child, Preschool | 4 | 2021 | 1146 | 0.110 |
Why?
|
| Activin Receptors, Type I | 1 | 2014 | 5 | 0.110 |
Why?
|
| Mitogen-Activated Protein Kinase 1 | 1 | 2014 | 22 | 0.110 |
Why?
|
| Hypoxia-Inducible Factor 1 | 1 | 2014 | 11 | 0.110 |
Why?
|
| Alternative Splicing | 2 | 2017 | 47 | 0.110 |
Why?
|
| Genes, myc | 2 | 2004 | 9 | 0.110 |
Why?
|
| Miosis | 1 | 2014 | 3 | 0.110 |
Why?
|
| Myopathies, Structural, Congenital | 1 | 2014 | 3 | 0.110 |
Why?
|
| Ichthyosis | 1 | 2014 | 6 | 0.110 |
Why?
|
| Blood Platelet Disorders | 1 | 2014 | 10 | 0.110 |
Why?
|
| Dyslexia | 1 | 2014 | 6 | 0.110 |
Why?
|
| Calcium Channels | 1 | 2014 | 33 | 0.110 |
Why?
|
| Migraine Disorders | 1 | 2014 | 22 | 0.110 |
Why?
|
| HLA-DQ beta-Chains | 4 | 2016 | 14 | 0.110 |
Why?
|
| Toxoplasma | 1 | 2014 | 33 | 0.110 |
Why?
|
| ets-Domain Protein Elk-1 | 1 | 2013 | 13 | 0.110 |
Why?
|
| Fluorometry | 1 | 2013 | 8 | 0.110 |
Why?
|
| Matrix Attachment Region Binding Proteins | 1 | 2013 | 4 | 0.110 |
Why?
|
| Nucleic Acid Hybridization | 1 | 2013 | 76 | 0.110 |
Why?
|
| RNA, Ribosomal, 16S | 1 | 2015 | 324 | 0.110 |
Why?
|
| Nanoparticles | 2 | 2008 | 287 | 0.110 |
Why?
|
| Protein Kinase C-delta | 1 | 2013 | 6 | 0.110 |
Why?
|
| Antibodies, Anticardiolipin | 2 | 2013 | 23 | 0.110 |
Why?
|
| Spleen | 1 | 2014 | 112 | 0.110 |
Why?
|
| Chromosomes, Human, Pair 11 | 2 | 2010 | 34 | 0.110 |
Why?
|
| Calcium Signaling | 1 | 2014 | 72 | 0.110 |
Why?
|
| Principal Component Analysis | 4 | 2016 | 51 | 0.110 |
Why?
|
| Cells, Cultured | 6 | 2016 | 985 | 0.100 |
Why?
|
| Interleukin-10 | 1 | 2013 | 72 | 0.100 |
Why?
|
| Aged | 7 | 2019 | 5400 | 0.100 |
Why?
|
| Toll-Like Receptor 7 | 1 | 2013 | 20 | 0.100 |
Why?
|
| Indians, South American | 1 | 2012 | 12 | 0.100 |
Why?
|
| DEAD-box RNA Helicases | 1 | 2013 | 26 | 0.100 |
Why?
|
| Regulatory Sequences, Nucleic Acid | 1 | 2012 | 26 | 0.100 |
Why?
|
| Protein Isoforms | 2 | 2010 | 119 | 0.100 |
Why?
|
| Transcription Factor HES-1 | 1 | 2012 | 6 | 0.100 |
Why?
|
| Thrombosis | 2 | 2005 | 149 | 0.100 |
Why?
|
| Chromatin Immunoprecipitation | 1 | 2012 | 29 | 0.100 |
Why?
|
| Cell Line | 3 | 2010 | 696 | 0.100 |
Why?
|
| Siblings | 2 | 2017 | 23 | 0.100 |
Why?
|
| HLA-DR2 Antigen | 2 | 2014 | 3 | 0.100 |
Why?
|
| Complement C1q | 1 | 2012 | 13 | 0.100 |
Why?
|
| HLA-DR3 Antigen | 2 | 2014 | 10 | 0.100 |
Why?
|
| Ikaros Transcription Factor | 1 | 2012 | 9 | 0.100 |
Why?
|
| Receptors, Notch | 1 | 2012 | 45 | 0.100 |
Why?
|
| Egg Proteins | 1 | 2012 | 17 | 0.100 |
Why?
|
| Dendritic Cells | 3 | 2020 | 142 | 0.100 |
Why?
|
| TNF Receptor-Associated Factor 6 | 1 | 2012 | 6 | 0.100 |
Why?
|
| V-Set Domain-Containing T-Cell Activation Inhibitor 1 | 1 | 2011 | 1 | 0.100 |
Why?
|
| Bayes Theorem | 4 | 2015 | 100 | 0.100 |
Why?
|
| Software | 1 | 2013 | 125 | 0.100 |
Why?
|
| Molecular Motor Proteins | 1 | 2011 | 13 | 0.100 |
Why?
|
| Point Mutation | 1 | 2012 | 60 | 0.100 |
Why?
|
| Homeodomain Proteins | 1 | 2012 | 79 | 0.100 |
Why?
|
| Apolipoproteins | 1 | 2011 | 21 | 0.090 |
Why?
|
| Basic Helix-Loop-Helix Transcription Factors | 1 | 2012 | 54 | 0.090 |
Why?
|
| DNA Primers | 3 | 2014 | 146 | 0.090 |
Why?
|
| Aneuploidy | 1 | 2011 | 21 | 0.090 |
Why?
|
| Myosin Heavy Chains | 1 | 2011 | 24 | 0.090 |
Why?
|
| Protein Phosphatase 2 | 1 | 2011 | 11 | 0.090 |
Why?
|
| Cell Adhesion Molecules | 1 | 2012 | 69 | 0.090 |
Why?
|
| Lipoproteins, HDL | 1 | 2011 | 41 | 0.090 |
Why?
|
| Sex Factors | 4 | 2017 | 466 | 0.090 |
Why?
|
| Complement Factor H | 1 | 2011 | 14 | 0.090 |
Why?
|
| Physical Chromosome Mapping | 3 | 2006 | 8 | 0.090 |
Why?
|
| Exodeoxyribonucleases | 1 | 2011 | 6 | 0.090 |
Why?
|
| Pyruvate Dehydrogenase Complex | 1 | 2010 | 19 | 0.090 |
Why?
|
| Hyaluronan Receptors | 1 | 2010 | 31 | 0.090 |
Why?
|
| Antigens, Neoplasm | 1 | 2011 | 56 | 0.090 |
Why?
|
| Mass Spectrometry | 1 | 2012 | 190 | 0.090 |
Why?
|
| Chromosomes, Human, Pair 1 | 3 | 2011 | 27 | 0.090 |
Why?
|
| Biomarkers | 2 | 2012 | 765 | 0.090 |
Why?
|
| Proteomics | 1 | 2012 | 181 | 0.080 |
Why?
|
| Image Enhancement | 2 | 2008 | 58 | 0.080 |
Why?
|
| Diabetes Mellitus, Type 1 | 1 | 2011 | 123 | 0.080 |
Why?
|
| Cell Nucleus | 1 | 2010 | 138 | 0.080 |
Why?
|
| HLA-DQ Antigens | 2 | 2016 | 25 | 0.080 |
Why?
|
| Photosensitivity Disorders | 1 | 2009 | 2 | 0.080 |
Why?
|
| Interleukin-21 Receptor alpha Subunit | 1 | 2009 | 4 | 0.080 |
Why?
|
| Gene Knockdown Techniques | 2 | 2021 | 134 | 0.080 |
Why?
|
| Homozygote | 3 | 2014 | 36 | 0.080 |
Why?
|
| Fibroblasts | 1 | 2010 | 157 | 0.080 |
Why?
|
| Lupus Erythematosus, Cutaneous | 1 | 2009 | 15 | 0.080 |
Why?
|
| P-Selectin | 1 | 2009 | 30 | 0.080 |
Why?
|
| Gene Knockout Techniques | 2 | 2020 | 35 | 0.080 |
Why?
|
| Genetics, Population | 2 | 2012 | 73 | 0.080 |
Why?
|
| CRISPR-Cas Systems | 2 | 2021 | 48 | 0.080 |
Why?
|
| ATP-Binding Cassette Transporters | 1 | 2009 | 38 | 0.080 |
Why?
|
| Mice, Inbred C57BL | 4 | 2020 | 1574 | 0.080 |
Why?
|
| Gadolinium | 1 | 2008 | 6 | 0.080 |
Why?
|
| Molecular Probe Techniques | 1 | 2008 | 6 | 0.080 |
Why?
|
| MicroRNAs | 1 | 2013 | 301 | 0.080 |
Why?
|
| Fluorine Radioisotopes | 1 | 2008 | 26 | 0.080 |
Why?
|
| Introns | 3 | 2013 | 43 | 0.070 |
Why?
|
| CD40 Antigens | 1 | 2008 | 14 | 0.070 |
Why?
|
| Mucopolysaccharidosis I | 1 | 2008 | 1 | 0.070 |
Why?
|
| Family Health | 2 | 2006 | 71 | 0.070 |
Why?
|
| Multipotent Stem Cells | 1 | 2008 | 5 | 0.070 |
Why?
|
| Heparitin Sulfate | 1 | 2008 | 14 | 0.070 |
Why?
|
| Osteosarcoma | 1 | 2008 | 16 | 0.070 |
Why?
|
| Cytokines | 1 | 2010 | 447 | 0.070 |
Why?
|
| Biomarkers, Tumor | 1 | 2011 | 404 | 0.070 |
Why?
|
| Bone Morphogenetic Proteins | 1 | 2008 | 32 | 0.070 |
Why?
|
| Enzyme-Linked Immunosorbent Assay | 2 | 2019 | 257 | 0.070 |
Why?
|
| Cell Line, Tumor | 3 | 2021 | 1319 | 0.070 |
Why?
|
| Heparin | 1 | 2008 | 111 | 0.070 |
Why?
|
| Protein Tyrosine Phosphatases | 2 | 2005 | 38 | 0.070 |
Why?
|
| Multifactorial Inheritance | 2 | 2017 | 13 | 0.070 |
Why?
|
| Mice, Transgenic | 3 | 2020 | 507 | 0.070 |
Why?
|
| Genetic Heterogeneity | 2 | 2013 | 31 | 0.070 |
Why?
|
| Gadolinium DTPA | 2 | 2004 | 14 | 0.070 |
Why?
|
| Transcriptome | 2 | 2021 | 214 | 0.070 |
Why?
|
| Genes, cdc | 1 | 2006 | 7 | 0.070 |
Why?
|
| Parotid Gland | 1 | 2006 | 6 | 0.070 |
Why?
|
| Salivation | 1 | 2006 | 11 | 0.060 |
Why?
|
| Cyclin D1 | 1 | 2006 | 38 | 0.060 |
Why?
|
| Magnetic Resonance Spectroscopy | 1 | 2006 | 180 | 0.060 |
Why?
|
| Statistics, Nonparametric | 2 | 2010 | 82 | 0.060 |
Why?
|
| Delaware | 1 | 2005 | 2 | 0.060 |
Why?
|
| Peru | 2 | 2016 | 30 | 0.060 |
Why?
|
| Gene Order | 1 | 2005 | 10 | 0.060 |
Why?
|
| Minnesota | 2 | 2009 | 42 | 0.060 |
Why?
|
| Base Pairing | 1 | 2005 | 25 | 0.060 |
Why?
|
| Base Composition | 1 | 2005 | 108 | 0.060 |
Why?
|
| Arteriosclerosis | 1 | 2004 | 29 | 0.060 |
Why?
|
| Zebrafish | 2 | 2017 | 96 | 0.060 |
Why?
|
| Epigenesis, Genetic | 2 | 2021 | 147 | 0.060 |
Why?
|
| Carotid Artery Diseases | 1 | 2004 | 37 | 0.060 |
Why?
|
| Blood Specimen Collection | 1 | 2004 | 14 | 0.060 |
Why?
|
| HLA-DQ alpha-Chains | 2 | 2016 | 8 | 0.060 |
Why?
|
| United Kingdom | 3 | 2009 | 76 | 0.060 |
Why?
|
| Phosphorylation | 4 | 2012 | 578 | 0.060 |
Why?
|
| Genes, ras | 1 | 2004 | 12 | 0.060 |
Why?
|
| RNA, Neoplasm | 1 | 2004 | 24 | 0.050 |
Why?
|
| Mucous Membrane | 1 | 2004 | 28 | 0.050 |
Why?
|
| Real-Time Polymerase Chain Reaction | 2 | 2016 | 133 | 0.050 |
Why?
|
| Proto-Oncogene Proteins c-bcl-2 | 1 | 2004 | 68 | 0.050 |
Why?
|
| Genes, Tumor Suppressor | 1 | 2004 | 39 | 0.050 |
Why?
|
| Age of Onset | 2 | 2017 | 70 | 0.050 |
Why?
|
| Reproducibility of Results | 3 | 2012 | 769 | 0.050 |
Why?
|
| Precursor Cell Lymphoblastic Leukemia-Lymphoma | 1 | 2004 | 41 | 0.050 |
Why?
|
| Nanostructures | 1 | 2004 | 64 | 0.050 |
Why?
|
| Oleic Acids | 1 | 2003 | 3 | 0.050 |
Why?
|
| Oleic Acid | 1 | 2003 | 4 | 0.050 |
Why?
|
| Phosphatidylethanolamines | 1 | 2003 | 26 | 0.050 |
Why?
|
| Matched-Pair Analysis | 2 | 2000 | 8 | 0.050 |
Why?
|
| Diet | 2 | 2015 | 232 | 0.050 |
Why?
|
| Reference Values | 1 | 2004 | 199 | 0.050 |
Why?
|
| Lupus Vulgaris | 1 | 2003 | 6 | 0.050 |
Why?
|
| Toll-Like Receptor 9 | 2 | 2016 | 7 | 0.050 |
Why?
|
| Infant | 2 | 2018 | 1004 | 0.050 |
Why?
|
| Gene Expression Regulation, Neoplastic | 1 | 2006 | 465 | 0.050 |
Why?
|
| Biopsy | 1 | 2004 | 206 | 0.050 |
Why?
|
| RNA | 1 | 2004 | 110 | 0.050 |
Why?
|
| Mice, Knockout | 2 | 2018 | 848 | 0.050 |
Why?
|
| Aged, 80 and over | 3 | 2015 | 2021 | 0.050 |
Why?
|
| Recurrence | 1 | 2004 | 322 | 0.050 |
Why?
|
| Prevalence | 2 | 2016 | 497 | 0.050 |
Why?
|
| Reactive Oxygen Species | 2 | 2017 | 285 | 0.050 |
Why?
|
| Mexico | 2 | 2016 | 89 | 0.050 |
Why?
|
| Neoplasm Staging | 1 | 2004 | 478 | 0.050 |
Why?
|
| Vitamins | 1 | 2022 | 23 | 0.050 |
Why?
|
| Tomography, X-Ray Computed | 1 | 2005 | 474 | 0.050 |
Why?
|
| Tumor Necrosis Factor-alpha | 2 | 2017 | 247 | 0.050 |
Why?
|
| Fetal Globulins | 1 | 2021 | 3 | 0.050 |
Why?
|
| Oklahoma | 2 | 2015 | 1007 | 0.050 |
Why?
|
| K562 Cells | 1 | 2021 | 20 | 0.050 |
Why?
|
| T-Lymphocytes | 2 | 2015 | 282 | 0.050 |
Why?
|
| New York | 1 | 2021 | 17 | 0.050 |
Why?
|
| Risk | 2 | 2011 | 137 | 0.050 |
Why?
|
| Datasets as Topic | 1 | 2021 | 22 | 0.040 |
Why?
|
| Receptors, Interferon | 1 | 2021 | 13 | 0.040 |
Why?
|
| Heredodegenerative Disorders, Nervous System | 1 | 2020 | 1 | 0.040 |
Why?
|
| Epigenomics | 1 | 2021 | 28 | 0.040 |
Why?
|
| Chromatin Assembly and Disassembly | 1 | 2021 | 20 | 0.040 |
Why?
|
| Gene Expression Regulation, Developmental | 1 | 2021 | 122 | 0.040 |
Why?
|
| Sequence Alignment | 1 | 2020 | 111 | 0.040 |
Why?
|
| Sensitivity and Specificity | 3 | 2012 | 521 | 0.040 |
Why?
|
| Protein Structure, Secondary | 1 | 2020 | 130 | 0.040 |
Why?
|
| Poly(ADP-ribose) Polymerases | 1 | 2000 | 22 | 0.040 |
Why?
|
| Lipids | 2 | 2018 | 208 | 0.040 |
Why?
|
| Amino Acid Substitution | 2 | 2012 | 103 | 0.040 |
Why?
|
| Flow Cytometry | 2 | 2016 | 288 | 0.040 |
Why?
|
| Autophagy | 1 | 2020 | 73 | 0.040 |
Why?
|
| Area Under Curve | 2 | 2011 | 95 | 0.040 |
Why?
|
| ROC Curve | 2 | 2011 | 144 | 0.040 |
Why?
|
| Protein Kinase C | 1 | 1999 | 73 | 0.040 |
Why?
|
| Isoenzymes | 1 | 1999 | 86 | 0.040 |
Why?
|
| Organ Specificity | 1 | 2019 | 82 | 0.040 |
Why?
|
| Genes, Recessive | 2 | 2012 | 21 | 0.040 |
Why?
|
| Mannosephosphates | 1 | 2018 | 5 | 0.040 |
Why?
|
| Cross-Sectional Studies | 1 | 2022 | 961 | 0.040 |
Why?
|
| Environment | 1 | 2019 | 65 | 0.040 |
Why?
|
| Golgi Apparatus | 1 | 2018 | 26 | 0.040 |
Why?
|
| Genetic Diseases, Inborn | 1 | 2018 | 20 | 0.040 |
Why?
|
| Basic-Leucine Zipper Transcription Factors | 1 | 2018 | 34 | 0.040 |
Why?
|
| Chondrocytes | 1 | 2018 | 27 | 0.040 |
Why?
|
| Lipogenesis | 1 | 2018 | 29 | 0.040 |
Why?
|
| Mutant Proteins | 1 | 2018 | 26 | 0.040 |
Why?
|
| COS Cells | 1 | 2018 | 49 | 0.040 |
Why?
|
| Monosaccharide Transport Proteins | 1 | 2018 | 23 | 0.040 |
Why?
|
| Cluster Analysis | 1 | 2018 | 125 | 0.040 |
Why?
|
| Up-Regulation | 2 | 2013 | 246 | 0.040 |
Why?
|
| Endoplasmic Reticulum | 1 | 2018 | 80 | 0.040 |
Why?
|
| Psychiatric Status Rating Scales | 1 | 2018 | 98 | 0.040 |
Why?
|
| Lysosomes | 1 | 2018 | 56 | 0.040 |
Why?
|
| Lectins, C-Type | 1 | 2018 | 43 | 0.040 |
Why?
|
| Insect Proteins | 1 | 1997 | 12 | 0.040 |
Why?
|
| Nephrotic Syndrome | 1 | 2017 | 8 | 0.040 |
Why?
|
| RNA, Transfer | 1 | 2017 | 16 | 0.040 |
Why?
|
| Telomere Homeostasis | 1 | 2017 | 10 | 0.040 |
Why?
|
| RNA Processing, Post-Transcriptional | 1 | 2017 | 20 | 0.040 |
Why?
|
| Fathers | 1 | 2017 | 15 | 0.040 |
Why?
|
| Podocytes | 1 | 2017 | 11 | 0.040 |
Why?
|
| Drosophila | 1 | 1997 | 32 | 0.040 |
Why?
|
| Cell Proliferation | 2 | 2013 | 806 | 0.040 |
Why?
|
| Cell Culture Techniques | 1 | 2018 | 116 | 0.040 |
Why?
|
| Mutagenesis, Insertional | 1 | 2017 | 38 | 0.030 |
Why?
|
| Zebrafish Proteins | 1 | 2017 | 20 | 0.030 |
Why?
|
| Homeostasis | 1 | 2018 | 118 | 0.030 |
Why?
|
| Metalloendopeptidases | 1 | 2017 | 39 | 0.030 |
Why?
|
| Sequence Deletion | 1 | 2017 | 66 | 0.030 |
Why?
|
| Cytoskeleton | 1 | 2017 | 44 | 0.030 |
Why?
|
| Chromosomes, Human, Pair 3 | 2 | 2008 | 17 | 0.030 |
Why?
|
| Collagen | 1 | 2018 | 156 | 0.030 |
Why?
|
| Fluorocarbons | 2 | 2008 | 6 | 0.030 |
Why?
|
| Endoplasmic Reticulum Stress | 1 | 2017 | 39 | 0.030 |
Why?
|
| Virus Diseases | 1 | 2017 | 39 | 0.030 |
Why?
|
| Interleukin-12 | 1 | 2017 | 19 | 0.030 |
Why?
|
| DNA Repair | 1 | 2017 | 82 | 0.030 |
Why?
|
| Recombinant Proteins | 2 | 2008 | 413 | 0.030 |
Why?
|
| Interferon-beta | 1 | 2017 | 40 | 0.030 |
Why?
|
| Protein Conformation | 1 | 2017 | 257 | 0.030 |
Why?
|
| Peptides | 1 | 1999 | 288 | 0.030 |
Why?
|
| Rats, Sprague-Dawley | 1 | 2018 | 551 | 0.030 |
Why?
|
| Severity of Illness Index | 1 | 2018 | 452 | 0.030 |
Why?
|
| Oligodeoxyribonucleotides | 1 | 2016 | 24 | 0.030 |
Why?
|
| 25-Hydroxyvitamin D3 1-alpha-Hydroxylase | 1 | 2016 | 2 | 0.030 |
Why?
|
| Vitamin D-Binding Protein | 1 | 2016 | 3 | 0.030 |
Why?
|
| Receptors, Calcitriol | 1 | 2016 | 6 | 0.030 |
Why?
|
| Follow-Up Studies | 1 | 2019 | 1013 | 0.030 |
Why?
|
| Republic of Korea | 1 | 2016 | 11 | 0.030 |
Why?
|
| Disease Models, Animal | 1 | 2002 | 1459 | 0.030 |
Why?
|
| Mitochondrial Proton-Translocating ATPases | 1 | 2016 | 8 | 0.030 |
Why?
|
| Argentina | 1 | 2016 | 9 | 0.030 |
Why?
|
| Chile | 1 | 2016 | 9 | 0.030 |
Why?
|
| Chromosomes, Human, Pair 10 | 1 | 2016 | 11 | 0.030 |
Why?
|
| Mothers | 1 | 2017 | 122 | 0.030 |
Why?
|
| Gene Dosage | 1 | 2016 | 35 | 0.030 |
Why?
|
| Trisomy | 1 | 2016 | 19 | 0.030 |
Why?
|
| Sex Distribution | 1 | 2016 | 78 | 0.030 |
Why?
|
| In Situ Hybridization, Fluorescence | 1 | 2016 | 75 | 0.030 |
Why?
|
| Tenascin | 1 | 2016 | 1 | 0.030 |
Why?
|
| Chromosomes, Human, Pair 2 | 1 | 2016 | 7 | 0.030 |
Why?
|
| Casein Kinase II | 1 | 2016 | 17 | 0.030 |
Why?
|
| Reverse Transcriptase Polymerase Chain Reaction | 1 | 2016 | 328 | 0.030 |
Why?
|
| Particle Size | 2 | 2006 | 101 | 0.030 |
Why?
|
| Cell Movement | 1 | 2017 | 373 | 0.030 |
Why?
|
| Inflammation Mediators | 1 | 2017 | 165 | 0.030 |
Why?
|
| Treponema | 1 | 2015 | 7 | 0.030 |
Why?
|
| Classification | 1 | 2015 | 15 | 0.030 |
Why?
|
| Actinobacteria | 1 | 2015 | 11 | 0.030 |
Why?
|
| Industrial Development | 1 | 2015 | 11 | 0.030 |
Why?
|
| Bacteroidetes | 1 | 2015 | 16 | 0.030 |
Why?
|
| Firmicutes | 1 | 2015 | 16 | 0.030 |
Why?
|
| Metabolome | 1 | 2015 | 68 | 0.030 |
Why?
|
| Receptors, Complement 3b | 1 | 2014 | 7 | 0.030 |
Why?
|
| Longitudinal Studies | 1 | 2016 | 414 | 0.030 |
Why?
|
| Metagenome | 1 | 2015 | 52 | 0.030 |
Why?
|
| Computer Simulation | 1 | 2016 | 230 | 0.030 |
Why?
|
| DNA, Protozoan | 1 | 2014 | 7 | 0.030 |
Why?
|
| Genome, Protozoan | 1 | 2014 | 6 | 0.030 |
Why?
|
| Benzodioxoles | 1 | 2014 | 5 | 0.030 |
Why?
|
| Host-Parasite Interactions | 1 | 2014 | 11 | 0.030 |
Why?
|
| ORAI1 Protein | 1 | 2014 | 6 | 0.030 |
Why?
|
| Erythrocytes, Abnormal | 1 | 2014 | 13 | 0.030 |
Why?
|
| Infant, Newborn | 1 | 2017 | 885 | 0.030 |
Why?
|
| Stromal Interaction Molecule 1 | 1 | 2014 | 8 | 0.030 |
Why?
|
| Patch-Clamp Techniques | 1 | 2014 | 31 | 0.030 |
Why?
|
| Catalytic Domain | 1 | 2014 | 79 | 0.030 |
Why?
|
| Drug Resistance | 1 | 2014 | 42 | 0.030 |
Why?
|
| Imidazoles | 1 | 2014 | 63 | 0.030 |
Why?
|
| Biodiversity | 1 | 2015 | 112 | 0.030 |
Why?
|
| In Vitro Techniques | 2 | 2005 | 241 | 0.030 |
Why?
|
| Protozoan Proteins | 1 | 2014 | 52 | 0.030 |
Why?
|
| Mutagenesis, Site-Directed | 1 | 2014 | 132 | 0.030 |
Why?
|
| Hyperplasia | 1 | 2013 | 27 | 0.030 |
Why?
|
| HLA-DR beta-Chains | 1 | 2013 | 2 | 0.030 |
Why?
|
| Sialyltransferases | 1 | 2013 | 5 | 0.030 |
Why?
|
| Histocompatibility Antigens Class II | 1 | 2013 | 58 | 0.030 |
Why?
|
| Fluorescent Antibody Technique | 1 | 2013 | 112 | 0.030 |
Why?
|
| NADH Dehydrogenase | 1 | 2013 | 6 | 0.030 |
Why?
|
| Receptors, CCR | 1 | 2013 | 2 | 0.030 |
Why?
|
| Nitric Oxide Synthase Type I | 1 | 2013 | 15 | 0.030 |
Why?
|
| Muscle Fatigue | 1 | 2014 | 77 | 0.030 |
Why?
|
| Exome | 1 | 2013 | 30 | 0.030 |
Why?
|
| Pyridines | 1 | 2014 | 107 | 0.030 |
Why?
|
| Electron Transport Complex I | 1 | 2013 | 13 | 0.030 |
Why?
|
| Glutathione Reductase | 1 | 2013 | 22 | 0.030 |
Why?
|
| Molecular Sequence Annotation | 1 | 2013 | 20 | 0.030 |
Why?
|
| Immune Tolerance | 1 | 2013 | 50 | 0.030 |
Why?
|
| Ku Autoantigen | 1 | 2013 | 12 | 0.030 |
Why?
|
| Transfection | 2 | 2008 | 318 | 0.030 |
Why?
|
| Antigens, Nuclear | 1 | 2013 | 22 | 0.030 |
Why?
|
| 3' Untranslated Regions | 1 | 2013 | 34 | 0.030 |
Why?
|
| Morbidity | 1 | 2012 | 58 | 0.030 |
Why?
|
| Lymphocytes | 1 | 2013 | 90 | 0.030 |
Why?
|
| HLA-B Antigens | 1 | 2012 | 29 | 0.030 |
Why?
|
| Codon, Initiator | 1 | 2012 | 6 | 0.020 |
Why?
|
| Computational Biology | 1 | 2013 | 155 | 0.020 |
Why?
|
| Intercellular Adhesion Molecule-1 | 1 | 2012 | 58 | 0.020 |
Why?
|
| Glyceraldehyde 3-Phosphate Dehydrogenase (NADP+) | 1 | 2011 | 3 | 0.020 |
Why?
|
| rac1 GTP-Binding Protein | 1 | 2011 | 18 | 0.020 |
Why?
|
| Proto-Oncogene Proteins c-vav | 1 | 2011 | 14 | 0.020 |
Why?
|
| Apolipoprotein L1 | 1 | 2011 | 10 | 0.020 |
Why?
|
| Interleukin-2 Receptor alpha Subunit | 1 | 2011 | 10 | 0.020 |
Why?
|
| Sex-Determining Region Y Protein | 1 | 2011 | 5 | 0.020 |
Why?
|
| DNA Mutational Analysis | 1 | 2012 | 94 | 0.020 |
Why?
|
| Databases, Genetic | 1 | 2012 | 48 | 0.020 |
Why?
|
| Quantitative Trait, Heritable | 1 | 2011 | 14 | 0.020 |
Why?
|
| Receptors, Androgen | 1 | 2011 | 26 | 0.020 |
Why?
|
| California | 1 | 2011 | 69 | 0.020 |
Why?
|
| Immunoglobulin G | 1 | 2013 | 270 | 0.020 |
Why?
|
| Kidney | 1 | 2013 | 286 | 0.020 |
Why?
|
| Crohn Disease | 1 | 2011 | 31 | 0.020 |
Why?
|
| Oral Ulcer | 1 | 2011 | 6 | 0.020 |
Why?
|
| Socioeconomic Factors | 1 | 2012 | 250 | 0.020 |
Why?
|
| Colitis, Ulcerative | 1 | 2011 | 31 | 0.020 |
Why?
|
| Plasmids | 1 | 2011 | 126 | 0.020 |
Why?
|
| Proteome | 1 | 2012 | 77 | 0.020 |
Why?
|
| Lupus Erythematosus, Discoid | 1 | 2011 | 18 | 0.020 |
Why?
|
| High-Throughput Screening Assays | 1 | 2011 | 38 | 0.020 |
Why?
|
| Gene Deletion | 1 | 2011 | 119 | 0.020 |
Why?
|
| Genomics | 1 | 2011 | 123 | 0.020 |
Why?
|
| Skin Physiological Phenomena | 1 | 2010 | 8 | 0.020 |
Why?
|
| Chi-Square Distribution | 1 | 2010 | 145 | 0.020 |
Why?
|
| Algorithms | 1 | 2013 | 430 | 0.020 |
Why?
|
| Korea | 1 | 2009 | 7 | 0.020 |
Why?
|
| Colombia | 1 | 2009 | 9 | 0.020 |
Why?
|
| Microarray Analysis | 1 | 2009 | 64 | 0.020 |
Why?
|
| Japan | 1 | 2009 | 23 | 0.020 |
Why?
|
| Meta-Analysis as Topic | 1 | 2009 | 32 | 0.020 |
Why?
|
| Demography | 1 | 2009 | 93 | 0.020 |
Why?
|
| 3-Phosphoinositide-Dependent Protein Kinases | 2 | 1999 | 2 | 0.020 |
Why?
|
| Tumor Necrosis Factor Receptor-Associated Peptides and Proteins | 1 | 2008 | 2 | 0.020 |
Why?
|
| Phosphatidylinositol Phosphates | 2 | 1999 | 11 | 0.020 |
Why?
|
| Glutathione Transferase | 2 | 1999 | 33 | 0.020 |
Why?
|
| Immunoglobulin M | 1 | 2008 | 28 | 0.020 |
Why?
|
| JNK Mitogen-Activated Protein Kinases | 1 | 2008 | 33 | 0.020 |
Why?
|
| Smad1 Protein | 1 | 2008 | 3 | 0.020 |
Why?
|
| Bone Morphogenetic Protein Receptors | 1 | 2008 | 4 | 0.020 |
Why?
|
| Inhibitor of Differentiation Protein 1 | 1 | 2008 | 7 | 0.020 |
Why?
|
| Sequence Homology, Amino Acid | 2 | 1999 | 132 | 0.020 |
Why?
|
| Bone Morphogenetic Protein 4 | 1 | 2008 | 14 | 0.020 |
Why?
|
| Enzyme Activation | 2 | 1999 | 267 | 0.020 |
Why?
|
| Confidence Intervals | 1 | 2008 | 68 | 0.020 |
Why?
|
| Intercellular Signaling Peptides and Proteins | 1 | 2008 | 66 | 0.020 |
Why?
|
| Proto-Oncogene Proteins | 2 | 1999 | 140 | 0.020 |
Why?
|
| Proto-Oncogene Proteins c-akt | 2 | 1999 | 155 | 0.020 |
Why?
|
| Recombinant Fusion Proteins | 2 | 1999 | 233 | 0.020 |
Why?
|
| Glycoproteins | 1 | 2008 | 122 | 0.020 |
Why?
|
| Age Factors | 1 | 2009 | 734 | 0.020 |
Why?
|
| Chromosomes, Human, Pair 13 | 1 | 2006 | 7 | 0.020 |
Why?
|
| Surveys and Questionnaires | 1 | 2010 | 971 | 0.020 |
Why?
|
| Iodized Oil | 1 | 2005 | 1 | 0.020 |
Why?
|
| Cell Differentiation | 1 | 2008 | 407 | 0.020 |
Why?
|
| Fluorine | 1 | 2004 | 5 | 0.010 |
Why?
|
| Biotinylation | 1 | 2004 | 19 | 0.010 |
Why?
|
| Endarterectomy, Carotid | 1 | 2004 | 11 | 0.010 |
Why?
|
| Emulsions | 1 | 2004 | 25 | 0.010 |
Why?
|
| Genomic Library | 1 | 2004 | 10 | 0.010 |
Why?
|
| Genes, Dominant | 1 | 2004 | 35 | 0.010 |
Why?
|
| North America | 1 | 2004 | 40 | 0.010 |
Why?
|
| Gene Rearrangement | 1 | 2004 | 14 | 0.010 |
Why?
|
| Genes, Immunoglobulin | 1 | 2004 | 10 | 0.010 |
Why?
|
| Interleukin-7 | 1 | 2004 | 10 | 0.010 |
Why?
|
| Self Tolerance | 1 | 2004 | 9 | 0.010 |
Why?
|
| bcl-X Protein | 1 | 2004 | 35 | 0.010 |
Why?
|
| Immunophenotyping | 1 | 2004 | 60 | 0.010 |
Why?
|
| Protein Tyrosine Phosphatase, Non-Receptor Type 1 | 1 | 2004 | 23 | 0.010 |
Why?
|
| Time Factors | 1 | 2008 | 1591 | 0.010 |
Why?
|
| Immunohistochemistry | 1 | 2004 | 463 | 0.010 |
Why?
|
| Biological Products | 1 | 2004 | 65 | 0.010 |
Why?
|
| Founder Effect | 1 | 2002 | 6 | 0.010 |
Why?
|
| Disease Progression | 1 | 2004 | 473 | 0.010 |
Why?
|
| Recombination, Genetic | 1 | 2002 | 62 | 0.010 |
Why?
|
| Chromosomes, Human, Pair 5 | 1 | 2000 | 10 | 0.010 |
Why?
|
| Africa | 1 | 2000 | 16 | 0.010 |
Why?
|
| Regression Analysis | 1 | 2000 | 210 | 0.010 |
Why?
|
| Phosphothreonine | 1 | 1999 | 5 | 0.010 |
Why?
|
| Phosphoserine | 1 | 1999 | 10 | 0.010 |
Why?
|
| Substrate Specificity | 1 | 1999 | 151 | 0.010 |
Why?
|
| Binding Sites | 1 | 1999 | 353 | 0.010 |
Why?
|
| Threonine | 1 | 1997 | 21 | 0.010 |
Why?
|
| Drosophila Proteins | 1 | 1997 | 44 | 0.010 |
Why?
|
| Blood Proteins | 1 | 1997 | 68 | 0.010 |
Why?
|
| Saccharomyces cerevisiae | 1 | 1999 | 174 | 0.010 |
Why?
|
| Rabbits | 1 | 1997 | 276 | 0.010 |
Why?
|
| Rats | 1 | 1999 | 1576 | 0.010 |
Why?
|
| Insulin-Like Growth Factor I | 1 | 1997 | 301 | 0.010 |
Why?
|
| Muscle, Skeletal | 1 | 1997 | 634 | 0.010 |
Why?
|